MTOR and head and neck squamous cell carcinoma: Alterations of the PI3K/AKT/mTOR pathway are common in HNSCC with a prevalence of activating mutations of PI3K of 56% and 39% in HPV-positive and HPV-negative HNSCC, respectively [70,71].